http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-336254-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5edd48190cba3fa70dd3975efd9831
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-108
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-108
filingDate 1967-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1968-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-336254-A2
titleOfInvention PROCEDURE FOR OBTAINING THERAPEUTICALLY ACTIVE ALPHA - PYRROLIDINOCETO- NAS.
abstract Improvements in the object of the main Patent No. 266,271 by: Process for the preparation of therapeutically active alpha-pyrrolidinocetones, of the general formula ** (See formula) ** wherein R represents a hydrogen atom, a lower alkyl radical, a lower alkoxy group, a hydroxyl group or a halogen atom, R 'an alkyl radical having 2 to 8 carbon atoms, and R "a hydrogen atom or an alcohol radical, characterized in that an α-pyrrolidinonitrile of the formula ** (See formula) ** wherein R 'and R "have the above meanings, is reacted with a phenyl-lithium of the formula ** (See formula) ** wherein R '' 'has the meanings of R, with the exception of a free hydroxyl group, the reaction being carried out in an anhydrous organic solvent, preferably at temperatures between -10 and + 40º C. and conveniently employing a slight excess of the phenyl-lithium compound, and in the case of producing a product in which R represents an alkoxy group, it is transformed, if desired, subsequently into a free hydroxyl group, in the manner in which yes known. (Machine-translation by Google Translate, not legally binding)
priorityDate 1966-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 15.